The OncoRat® Is The Ideal Host For Patient-Derived Xenografts Of Ovarian Cancer Cells Insightful Insights, IVO, Precision Toxicology and Efficacy News The OncoRat® Is The Ideal Host For Patient-Derived Xenografts Of Ovarian Cancer Cells Ovarian cancer is the most lethal gynecological cancer in the [...] Jack Crawford2022-02-16T09:52:11+00:00Tags: Analise DiFeo, TCGA, The Cancer Genome Atlas, NSG Mice, Chemo-induced stemness, gynecological Cancer, ovarian cancer, OV81.2, OV81, Immunodeficient Rats, Cancer Xenografts, drug resistance, in vivo model, Humanized Rats, Cell Line Xenografts, Xenografts, Oncology, OncoRat, drug discovery, rat model, Cancer, Hera Biolabs, oncology models, preclinical| Read More